The Allen Institute is launching a $200 million initiative, the Brain Health Accelerator, to develop gene therapies for neurodegenerative diseases including Alzheimer's, Parkinson's, Huntington's, and ALS. It marks the first time the Seattle research organization, founded by Paul Allen in 2003, has made treating disease its goal. Read More
Vollständiger Original-Bericht
Ausführliche Details, Code-Beispiele & Hersteller-Stellungnahme auf geekwire.com.
SOCIAL SHARE CARD GENERATOR